Gareth Jones
www.abdn.ac.uk
0000-0003-0016-7591
University of Aberdeen
13 papers found
Refreshing results…
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis register
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis
The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis
Quantifying and predicting the effect of anti-TNF therapy on axSpA-related fatigue: results from the BSRBR-AS registry and meta-analysis
Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
Maintaining Musculoskeletal Health Using a Behavioural Therapy Approach: A Population-Based Randomised Controlled Trial (The MAmMOTH Study)
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Maintained physical activity and physiotherapy in the management of distal arm pain: a randomised controlled trial
Missing publications? Search for publications with a matching author name.